Schneider Sophie

Hinterberger Sarah, Schneider Sophie, Kallab Martin, Murauer Olivia, Reisinger Anna-Sophie, Bolz Matthias et al.

This real-world study found the Preserflo MicroShunt achieved 60.5% overall success at two years, significantly reducing IOP and medication, offering a viable surgical option for diverse glaucoma patients.

Schneider Sophie, Kallab Martin, Murauer Olivia, Reisinger Anna-Sophie, Strohmaier Susanne, Huang Alex S et al.

Early bleb vessel density measured by AS-OCTA after Preserflo Microshunt surgery predicts future surgical revisions, offering an objective biomarker for bleb failure risk.